BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Results support robot-assisted surgeries for prostatectomies

Sep. 17, 2013
By Omar Ford
An independent study published online in the journal Urology found that minimally invasive surgery for prostate cancer significantly reduces complications when compared to open surgery. The study found that minimally invasive surgery for prostate cancer, including laparoscopic and robotic-assisted surgery, was associated with lower transfusion rates, shorter length of hospital stay, and lower serious postoperative complication and mortality rates compared to open prostatectomy.
Read More

Years in the making, Aethlon launches Exosome subsidiary

Sep. 16, 2013
By Omar Ford
Aethlon Medical (San Diego) reported the formal launch of Exosome Sciences (ESI), a wholly-owned subsidiary previously established by to pursue exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease and other life-threatening conditions.
Read More

TherOx seeks PMA for SSO2 device for infarct reduction

Sep. 13, 2013
By Omar Ford
One small med-tech firm is developing a system that is intended to provide interventional cardiologists with the first treatment option beyond percutaneous coronary intervention (PCI) to salvage heart muscle in heart attack patients.
Read More

Testing Anxiety: A case for more POC diagnostics

Sep. 12, 2013
By Omar Ford
A routine physical turned out to be a nightmare for me last year when it was discovered that my white blood cell count was significantly low. It was also the catalyst behind my drive to make sure that any physician I go to now can get overnight if not instant results from a lab once my sample is being tested. At the time, I was just getting over a severe cold that I had received from my now 2-year-old daughter - which was the ultimate culprit of the white blood cell shortage. However, at the time, when I questioned the...
Read More

Gore gets FDA nod for device torepair descending thoracic aortas

Sep. 12, 2013
By Omar Ford

2013 seen as a disappointing year for med-tech sector so far

Sep. 11, 2013
By Omar Ford

Cook launches LithAssist to aid in PCNL procedures

Sep. 9, 2013
By Omar Ford
Cook Medical (Bloomington, Indiana) reported that it has developed a new device to simplify percutaneous nephrolithotomy (PCNL) procedures, during which physicians break up and remove large kidney stones, or can use it in the bladder to break up large bladder stones.
Read More

TransEnterix merges with SafeStitch, becomes public

Sep. 5, 2013
By Omar Ford

Procedure removes lymph nodes without long-term complications

Sep. 3, 2013
By Omar Ford
Malignant melanoma is the leading cause of skin cancer death in the U.S. and it s a cancer that kills one person every hour, which translates to more than 8,700 Americans each year. Often times when it occurs in the lower part of the body treatment can be intense and have some complications for patients.
Read More

Lombard seeks stronger U.S. presence in AAA repair market

Aug. 30, 2013
By Omar Ford
Previous 1 2 … 102 103 104 105 106 107 108 109 110 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 14, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 14, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing